These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 15270784

  • 1. Sex-differences in prevalence of electrocardiographic left ventricular hypertrophy in Type 2 diabetes: the Casale Monferrato Study.
    Bruno G, Giunti S, Bargero G, Ferrero S, Pagano G, Perin PC.
    Diabet Med; 2004 Aug; 21(8):823-8. PubMed ID: 15270784
    [Abstract] [Full Text] [Related]

  • 2. T-wave axis deviation and left ventricular hypertrophy interaction in diabetes and hypertension.
    Assanelli D, Di Castelnuovo A, Rago L, Badilini F, Vinetti G, Gianfagna F, Salvetti M, Zito F, Donati MB, de Gaetano G, Iacoviello L, Moli-sani Project Investigators.
    J Electrocardiol; 2013 Aug; 46(6):487-91. PubMed ID: 24011993
    [Abstract] [Full Text] [Related]

  • 3. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
    Palmieri V, Okin PM, de Simone G, Bella JN, Wachtell K, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB.
    J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
    [Abstract] [Full Text] [Related]

  • 4. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
    Nardi E, Palermo A, Mulè G, Cusimano P, Cerasola G, Rini GB.
    Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM.
    J Electrocardiol; 2009 Oct; 42(6):584-8. PubMed ID: 19631946
    [Abstract] [Full Text] [Related]

  • 7. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B, Losartan Intervention for Endpoint reduction in hypertension Study Investigations.
    Circulation; 2003 Aug 12; 108(6):684-90. PubMed ID: 12885747
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular prognosis in patients with type 2 diabetes: contribution of heart and kidney subclinical damage.
    Sosner P, Hulin-Delmotte C, Saulnier PJ, Cabasson S, Gand E, Torremocha F, Piguel X, Miot A, Maréchaud R, Herpin D, Ragot S, Hadjadj S, SURDIAGENE Study Group.
    Am Heart J; 2015 Jan 12; 169(1):108-14.e7. PubMed ID: 25497255
    [Abstract] [Full Text] [Related]

  • 9. Obesity and ECG left ventricular hypertrophy.
    Muiesan ML, Salvetti M, Di Castelnuovo A, Paini A, Assanelli D, Costanzo S, Badilini F, Vaglio M, Donati MB, Agabiti Rosei E, de Gaetano G, Iacoviello L, Moli-sani Study Investigators.
    J Hypertens; 2017 Jan 12; 35(1):162-169. PubMed ID: 27662187
    [Abstract] [Full Text] [Related]

  • 10. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
    González-Juanatey JR, Cea-Calvo L, Bertomeu V, Aznar J, for Investigators study VIIDA.
    Rev Esp Cardiol; 2007 Feb 12; 60(2):148-56. PubMed ID: 17338880
    [Abstract] [Full Text] [Related]

  • 11. Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study.
    Cea-Calvo L, Conthe P, Gómez-Fernández P, de Alvaro F, Fernández-Pérez C, RICARHD investigators.
    Cardiovasc Diabetol; 2006 Nov 03; 5():23. PubMed ID: 17083718
    [Abstract] [Full Text] [Related]

  • 12. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
    Okin PM, Devereux RB, Gerdts E, Snapinn SM, Harris KE, Jern S, Kjeldsen SE, Julius S, Edelman JM, Lindholm LH, Dahlöf B, LIFE Study Investigators.
    Circulation; 2006 Mar 28; 113(12):1588-96. PubMed ID: 16534012
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and covariates of electrocardiographic left ventricular hypertrophy in diabetic patients in Tanzania.
    Lutale JJ, Thordarson H, Gulam-Abbas Z, Vetvik K, Gerdts E.
    Cardiovasc J Afr; 2008 Mar 28; 19(1):8-14. PubMed ID: 18320079
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and covariates of electrocardiographic left ventricular hypertrophy in the Hypertension in the Very Elderly Trial.
    Antikainen RL, Beckett N, Peters R, Fagard R, Rajkumar C, Wang J, Stoyanovsky V, Barrowdale D, Bulpitt CJ, HYVET Study Group.
    J Hypertens; 2013 Jun 28; 31(6):1224-32. PubMed ID: 23588194
    [Abstract] [Full Text] [Related]

  • 15. Mild renal dysfunction is associated with electrocardiographic left ventricular hypertrophy.
    Smilde TD, Asselbergs FW, Hillege HL, Voors AA, Kors JA, Gansevoort RT, van Gilst WH, de Jong PE, Van Veldhuisen DJ.
    Am J Hypertens; 2005 Mar 28; 18(3):342-7. PubMed ID: 15797651
    [Abstract] [Full Text] [Related]

  • 16. Accuracy and prognostic significance of electrocardiographic markers of left ventricular hypertrophy in a general population: findings from the Pressioni Arteriose Monitorate E Loro Associazioni population.
    Cuspidi C, Facchetti R, Bombelli M, Sala C, Grassi G, Mancia G.
    J Hypertens; 2014 Apr 28; 32(4):921-8. PubMed ID: 24406778
    [Abstract] [Full Text] [Related]

  • 17. Electrocardiographic left ventricular hypertrophy and arterial stiffness: the Ohasama study.
    Watabe D, Hashimoto J, Hatanaka R, Hanazawa T, Ohba H, Ohkubo T, Kikuya M, Totsune K, Imai Y.
    Am J Hypertens; 2006 Dec 28; 19(12):1199-205. PubMed ID: 17161763
    [Abstract] [Full Text] [Related]

  • 18. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A, Barrios V, Escobar C, Ferrer E, Barrios S, González-Pedel V, Montoro P, Navarro-Cid J.
    Clin Exp Hypertens; 2010 May 28; 32(3):145-53. PubMed ID: 20504121
    [Abstract] [Full Text] [Related]

  • 19. Electrocardiographic left ventricular hypertrophy criteria and ambulatory blood pressure monitoring parameters in adults.
    Gómez-Marcos MA, Recio-Rodríguez JI, Patino-Alonso MC, Agudo-Conde C, Fernandez-Alonso C, Martinez Vizcaino V, Cantera CM, Guenaga-Saenz N, González-Viejo N, García-Ortiz L, EVIDENT Study, Spain.
    Am J Hypertens; 2014 Mar 28; 27(3):355-62. PubMed ID: 24190901
    [Abstract] [Full Text] [Related]

  • 20. Home-measured blood pressure is more strongly associated with electrocardiographic left ventricular hypertrophy than is clinic blood pressure: the Finn-HOME study.
    Niiranen TJ, Jula AM, Kantola IM, Karanko H, Reunanen A.
    J Hum Hypertens; 2007 Oct 28; 21(10):788-94. PubMed ID: 17637793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.